Theo M. Luider

Papers

Total Citations

120

H-Index

About

Theo M. Luider is a leading figure in analytical chemistry and neuro-oncology, renowned for pioneering mass spectrometry applications in both pharmaceutical analysis and brain tumor biology. His work bridges the gap between precise drug quantification and the molecular characterization of gliomas. In a seminal 2006 study, Luider established critical protocols for MALDI-TOF mass spectrometry in pharmaceutical analysis, addressing matrix selection, cationization, and automation—a methodological cornerstone that has garnered 63 citations and continues to guide quantitative drug assays. Simultaneously, his 2004 investigation into glioma neovascularization revealed the differential expression of CALD1 splicing variants in tumor versus normal brain microvasculature, a discovery with 57 citations that illuminates vascular remodeling in gliomas. This dual expertise—developing robust analytical tools while unraveling disease-specific molecular signatures—positions Luider as a transformative researcher. His work not only advances the sensitivity and reliability of mass spectrometry but also provides critical insights into tumor biology, impacting fields from pharmacology to neuropathology. For students and researchers, Luider exemplifies how technical innovation can drive biological discovery, making his contributions essential reading for those exploring the intersection of analytical chemistry and cancer research.